Showing results (71-80 of 134) with videos related to
Sort By:
Pageof 14
Hernia : the Journal of Hernias and Abdominal Wall Surgery|December 1, 2019
Seroma prevention strategies in laparoscopic ventral hernia repair: a systematic reviewC He, J Lu, M W Ong, et al.Journal of Bone Oncology|November 19, 2015
Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-studyChristina L Addison, Gregory R Pond, Brandy Cochrane, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifenH F Kennecke, I A Olivotto, C Speers, et al.Bioresource Technology|December 26, 2012
Production of methanol from biomass waste via pyrolysisS K Kamarudin, N S Shamsul, J A Ghani, et al.British Dental Journal|December 16, 2017
MRONJ risk of adjuvant bisphosphonates in early stage breast cancerV Patel, J Mansi, S Ghosh, et al.Journal of the American College of Cardiology|November 25, 2000
Transmitral Doppler: a new transthoracic contrast method for patent foramen ovale detection and quantificationA J Kerr, T Buck, K Chia, et al.Breast Cancer Research and Treatment|February 12, 2009
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patientsShuzhen Liu, Stephen K Chia, Erika Mehl, et al.The Journal of Arthroplasty|October 31, 2012
Peri-articular steroid injection in total knee arthroplasty: a prospective, double blinded, randomized controlled trialSamuel K Chia, Gregory C Wernecke, Ian A Harris, et al.The Malaysian Journal of Pathology|December 28, 2023
MicroRNA profiling in complete and partial hydatidiform molesW K Chia, H X Y Yeoh, M Mustangin, et al.Investigational New Drugs|July 14, 2005
A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancerKim N Chi, Stephen K Chia, Ross Dixon, et al.Pageof 14